Featured Research

from universities, journals, and other organizations

"Bionic Ear" Implanted By Penn Surgeons To Give Hearing To The Deaf: FDA-Approved Device Provides The World's Fastest Hearing Technology

Date:
August 1, 2001
Source:
University Of Pennsylvania Medical Center
Summary:
Doctors at the University of Pennsylvania Medical Center’s Department of Otorhinolaryngology are now surgically implanting the recently FDA-approved “bionic ear,” bringing hearing to once-deaf adults throughout the Delaware Valley.

Philadelphia, PA – Doctors at the University of Pennsylvania Medical Center’s Department of Otorhinolaryngology are now surgically implanting the recently FDA-approved “bionic ear,” bringing hearing to once-deaf adults throughout the Delaware Valley.

Surgeons and audiologists from Penn are the first in Pennsylvania to implant this device and are participating in current clinical trials assessing the benefits of the new capabilities of the CII Bionic Ear. The Bionic Ear is marketed by Advanced Bionics Corporation under the trade name CLARIONฎ CII Bionic Earฎ. It can deliver sound information directly to the hearing nerve up to 1 million times a second– significantly faster than conventional cochlear implant technology– which delivers sound information under 20,000 times each second.

“The Bionic Ear is a great advance in cochlear implant technology,” said Douglas C. Bigelow, MD, senior neurotologist at Penn who, along with neurotologist Michael Ruckenstein, MD, has implanted over 100 profoundly deaf adults with cochlear implants. Dr. Bigelow serves as Principal Investigator in the proposed clinical study of the CII Bionic Ear. “The new advanced speech processing strategies used in this implant have the potential to help people with severe to profound hearing loss regain much of their hearing. The improvement in quality-of-life that this technology offers can be quite dramatic.”

Conventional cochlear implants do not have internal electronic memory banks and control electronics to store hearing programs directly in the implant. Therefore, they rely on the external sound processor to continuously transmit all hearing program instruction to the implant electronics.

Continuous transmission of hearing program parameters occupies much of the data and information pipeline to the implant and leaves limited room for the transmission of detailed sound signal. As a result, conventional cochlear implants can deliver only a small, custom subset of full sound signals to the hearing nerve, and must discard many of the important fine details of speech and sound.

The high resolution CI Bionic Ear can directly store all hearing program parameters in the internal electronic memory banks, leaving the data and information pipeline open for the fine details of sound. This advance design allows the miniature sound processor to be dedicated to transmitting the full broadband signal to the powerful electronics of the Bionic Ear, resulting in more and better sound information delivered to the hearing nerve in much greater detail.

“Today, more and more patients achieve higher levels of speech understanding in shorter periods of time. The CII Bionic Ear System can offer patients fuller sound signals at faster speeds,” said Michelle Montes, MS, coordinator of cochlear implant services in Penn’s department of Audiology. “These advancements have the potential to provide more detailed speech and sound information with improved fidelity. The CII technology will undoubtedly contribute to growth in patient benefit and provide an invaluable platform for future cochlear implant improvements. It’s exciting to be a part of this process.”

Candidates for the new Bionic Ear include children who are born deaf and adults who have lost their hearing. Most health insurance carriers, including Medicare, cover the cost of the implanted device and surgery. The surgery, which takes between two and four hours, does require follow-up treatment. Patients will need multiple outpatient appointments with an audiologist.


Story Source:

The above story is based on materials provided by University Of Pennsylvania Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

University Of Pennsylvania Medical Center. ""Bionic Ear" Implanted By Penn Surgeons To Give Hearing To The Deaf: FDA-Approved Device Provides The World's Fastest Hearing Technology." ScienceDaily. ScienceDaily, 1 August 2001. <www.sciencedaily.com/releases/2001/08/010801082144.htm>.
University Of Pennsylvania Medical Center. (2001, August 1). "Bionic Ear" Implanted By Penn Surgeons To Give Hearing To The Deaf: FDA-Approved Device Provides The World's Fastest Hearing Technology. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/2001/08/010801082144.htm
University Of Pennsylvania Medical Center. ""Bionic Ear" Implanted By Penn Surgeons To Give Hearing To The Deaf: FDA-Approved Device Provides The World's Fastest Hearing Technology." ScienceDaily. www.sciencedaily.com/releases/2001/08/010801082144.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) — Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) — Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) — At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) — Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins